company_name,company_ticker,company_lei,company_cik,year,quarter,start_date,end_date,filing_date,parent,tag,financial_name,factor,balance,unit,value
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3411000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3411000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3411000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3364000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,13425000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,16789000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-13378000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,490000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,490000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67944000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.19
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67944000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.19
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q1,2010-07-01,2010-09-30,2011-10-31 09:48:04+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.19
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4178000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4178000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4178000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,3688000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16004000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,19692000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15514000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,1281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,1281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-14233000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67965000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.21
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67965000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.21
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,67800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q2,2010-10-01,2010-12-31,2012-01-31 10:01:32+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.21
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5211000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5211000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5211000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4550000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15763000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20313000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-15102000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,99000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,99000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-15003000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68067000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.22
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68067000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.22
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q3,2011-01-01,2011-03-31,2012-05-10 14:10:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.22
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6505000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6505000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6505000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4438000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,18261000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22699000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-16194000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,218000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalotherincome,otherincome,"Other Income / (Expense), net",+,credit,usd,-1870000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1652000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17846000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1696000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-16150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-16150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-16150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,68600000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.23
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,68600000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.23
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,68919000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2010.0,Q4,2011-04-01,2011-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.23
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2536000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2536000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2536000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4841000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,17161000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,22002000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-19466000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-19466000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-17000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-19483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-19483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-19483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,74900000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,74900000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76364000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q1,2011-07-01,2011-09-30,2012-10-31 10:15:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7617000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7617000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7617000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4834000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,15559000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,20393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12776000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-12776000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,23000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-12753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-12753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-12753000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,75000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.17
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,75000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.17
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76523000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q2,2011-10-01,2011-12-31,2013-01-30 15:05:27+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.17
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3252000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3252000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3252000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5021000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,16933000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,21954000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-18702000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-18702000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,33000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-18669000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-18669000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-18669000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.24
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.24
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76961000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q3,2012-01-01,2012-03-31,2013-05-06 10:19:54+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.24
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2952000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2952000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2952000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5726000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,19539000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25265000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-22313000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,66000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,66000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-22247000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-167000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22414000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,77200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,77200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,76814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2011.0,Q4,2012-04-01,2012-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,4091000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,4091000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,4091000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5639000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,23700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,29339000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25248000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-25248000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,56000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-25192000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-25192000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-25192000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,83350000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q1,2012-07-01,2012-09-30,2013-10-29 10:24:38+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,2612000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,2612000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,2612000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5464000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21656000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,27120000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-24508000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-24508000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,115000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-24393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-24393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-24393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,84147000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,84147000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q2,2012-10-01,2012-12-31,2014-02-05 12:24:56+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,25001000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,25001000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,25001000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,4995000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21318000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26313000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-1312000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-1312000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-39000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-1351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-1351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-1351000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,67600000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.02
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,67600000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.02
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84279000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q3,2013-01-01,2013-03-31,2014-05-02 13:15:50+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.02
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,3831000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,3831000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,3831000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5373000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20399000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,25772000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21941000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,126000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,126000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21815000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-60000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,83700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,83700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,84063000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2012.0,Q4,2013-04-01,2013-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,17218000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,17218000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,17218000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6526000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,22029000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,28555000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-11337000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-11337000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,111000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-11226000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-11226000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-11226000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86400000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.13
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86400000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.13
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85010000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q1,2013-07-01,2013-09-30,2014-10-30 14:15:03+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.13
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,30060000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,30060000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,30060000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,5447000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,20862000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,26309000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,3751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,62000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,3813000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,3813000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,3813000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85431000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87276000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,95300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q2,2013-10-01,2013-12-31,2015-02-05 15:32:46+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,6875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,6875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,6875000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6040000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38280000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44320000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-37445000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-37445000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-7000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-37452000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-37452000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-37452000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.44
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85100000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.44
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85684000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q3,2014-01-01,2014-03-31,2015-05-08 13:38:31+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.44
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,5743000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,5743000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,5743000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6456000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25787000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32243000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-26500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,44000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,44000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-26456000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-43000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-26499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-26499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-26499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85481000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2013.0,Q4,2014-04-01,2014-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13203000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7095000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28018000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,35113000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21910000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,8000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,8000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21902000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-380000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-22282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-22282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-22282000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85872000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q1,2014-07-01,2014-09-30,2015-10-30 11:44:57+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.26
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,48300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,48300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,48300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,6872000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,27647000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,34519000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,13781000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,13795000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-160000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,13635000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,13635000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,13635000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85935000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,0.16
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86665000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.16
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,85200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q2,2014-10-01,2014-12-31,2016-02-04 10:10:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.16
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,11427000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,11427000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,11427000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,25666000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,32666000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-21239000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,14000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,14000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21225000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86080000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.25
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.25
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q3,2015-01-01,2015-03-31,2016-05-04 15:56:06+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.25
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,12611000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,12611000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,12611000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7261000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,30437000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,37698000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-25087000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5437000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,33000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5404000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-30491000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,17000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-30474000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-30474000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-30474000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,85500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.36
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,85500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.36
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86038000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2014.0,Q4,2015-04-01,2015-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.36
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,14851000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,14851000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,14851000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35132000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,43461000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28610000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5143000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,51000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-5092000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33702000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-38000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33740000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33740000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33740000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.39
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.39
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86838000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q1,2015-07-01,2015-09-30,2016-11-04 16:13:10+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.39
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,18029000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,18029000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,18029000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8054000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38199000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46253000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-28224000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5059000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,60000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4999000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-33223000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-4000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-33227000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-33227000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-33227000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86970000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.38
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86970000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.38
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87400000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q2,2015-10-01,2015-12-31,2016-02-04 10:10:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.38
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19714000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19714000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19714000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,11235000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,36094000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47329000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-27615000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4972000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,108000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4864000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-32479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,551000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-31928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-31928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-31928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.37
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.37
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87035000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q3,2016-01-01,2016-03-31,2017-05-05 14:00:09+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.37
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7408000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7408000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7408000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9298000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38652000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,47950000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40542000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5094000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,106000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4988000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-45530000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-392000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-45922000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-45922000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-45922000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.53
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.53
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,86976000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2015.0,Q4,2016-04-01,2016-06-30,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.53
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,7660000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,7660000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,7660000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9459000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32909000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,4130000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,46498000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38838000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,6168000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,146000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-6022000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-44860000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,129000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-44731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-44731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-44731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,87700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.51
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,87700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.51
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87102000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2016.0,Q1,2016-07-01,2016-09-30,2017-11-09 15:27:14+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.51
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,28499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,28499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,28499000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8119000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,32888000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,386000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,41393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-12894000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,115000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4585000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-17479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,134000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-17345000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-17345000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-17345000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,86700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.2
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,86700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.2
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87160000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q1,2017-01-01,2017-03-31,2018-05-09 16:21:47+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.2
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39020000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39020000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39020000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8836000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,35319000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,44155000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-5135000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4626000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,143000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4483000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-9618000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-8867000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-8867000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-8867000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,88700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.1
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,88700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.1
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,87174000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q2,2017-04-01,2017-06-30,2018-08-03 11:30:05+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.1
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8480000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8480000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8480000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,7908000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,31689000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,39597000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-31117000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,26338000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,293000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-26045000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-57162000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,480000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-56682000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-56682000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-56682000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,92900000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.61
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,92900000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.61
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,93001000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q3,2017-07-01,2017-09-30,2018-11-02 11:43:58+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.61
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,39448000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,39448000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,39448000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9048000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,39843000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,393000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,49284000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-9836000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3973000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,595000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3378000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-13214000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,96000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-13118000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-13118000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-13118000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,98000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.07
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,98000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.07
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,98068000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2017.0,Q4,2017-10-01,2017-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.07
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,19815000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,19815000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,19815000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9995000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,44831000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1731000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56557000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-36742000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3070000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,662000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2408000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-39150000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,537000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-38613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-38613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-38613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,128700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,128700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,130619000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q1,2018-01-01,2018-03-31,2019-05-07 15:55:51+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,9287000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,9287000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,9287000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8652000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38701000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,686000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,48039000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-38752000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2634000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1820000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-40572000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-1052000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41624000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41624000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41624000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,134300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.31
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,134300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.31
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,134384000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q2,2018-04-01,2018-06-30,2019-08-07 16:48:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.31
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,10928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,10928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,10928000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8347000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,47243000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,870000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56460000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-45532000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2569000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1369000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1200000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-46732000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-75000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-46807000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-46807000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-46807000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,146300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.32
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,146300000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.32
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,147220000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q3,2018-07-01,2018-09-30,2019-11-05 17:30:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.32
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13416000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13416000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13416000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9752000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,43681000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,406000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,53839000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-40423000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,2453000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1382000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-1071000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-41494000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-305000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-41799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-41799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-41799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,139500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,139500000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,139946000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2018.0,Q4,2018-10-01,2018-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.28
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,8584000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,8584000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,8584000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,10778000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,38893000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,559000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,50230000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41646000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3456000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1422000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2034000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43680000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-71000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43751000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,147813000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q1,2019-01-01,2019-03-31,2020-05-05 15:18:02+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.3
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,15542000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,15542000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,15542000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,8700000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,28559000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,19342000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,56601000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-41059000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,3841000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1287000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-2554000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-43613000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,167000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-43446000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-43446000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-43446000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,149800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,149800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,148129000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q2,2019-04-01,2019-06-30,2019-08-07 16:48:20+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.29
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,13281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,13281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,13281000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9208000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,21015000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,1020000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,31243000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,-17962000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,4299000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,1032000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-3267000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,-21229000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,-521000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,-21750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,-21750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,-21750000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,145000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,,basiceps,Basic Earnings per Share,=,,usdpershare,-0.15
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,145000000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,-0.15
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,148479000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q3,2019-07-01,2019-09-30,2019-11-05 17:30:43+00:00,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,-0.15
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalrevenue,operatingrevenue,Operating Revenue,+,credit,usd,44864000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalgrossprofit,totalrevenue,Total Revenue,+,credit,usd,44864000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totalgrossprofit,Total Gross Profit,+,credit,usd,44864000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,sgaexpense,"Selling, General & Admin Expense",+,debit,usd,9803000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,rdexpense,Research & Development Expense,+,debit,usd,26055000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingexpenses,restructuringcharge,Restructuring Charge,+,debit,usd,512000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totaloperatingincome,totaloperatingexpenses,Total Operating Expenses,-,debit,usd,36370000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totaloperatingincome,Total Operating Income,+,credit,usd,8494000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestexpense,Interest Expense,-,debit,usd,5378000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalotherincome,totalinterestincome,Interest & Investment Income,+,credit,usd,683000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,totalpretaxincome,totalotherincome,"Total Other Income / (Expense), net",+,credit,usd,-4695000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,totalpretaxincome,Total Pre-Tax Income ,+,credit,usd,3799000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netincomecontinuing,othergains,"Other Gains / (Losses), net",+,credit,usd,1015000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netincome,netincomecontinuing,Net Income / (Loss) Continuing Operations,+,credit,usd,4814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,netincometocommon,netincome,Consolidated Net Income / (Loss),+,credit,usd,4814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,netincometocommon,Net Income / (Loss) Attributable to Common Shareholders,=,credit,usd,4814000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,basiceps,weightedavebasicsharesos,Weighted Average Basic Shares Outstanding,/,,shares,148800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,basiceps,Basic Earnings per Share,=,,usdpershare,0.04
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,dilutedeps,weightedavedilutedsharesos,Weighted Average Diluted Shares Outstanding,/,,shares,148800000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,dilutedeps,Diluted Earnings per Share,=,,usdpershare,0.04
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,basicdilutedeps,weightedavebasicdilutedsharesos,Weighted Average Basic & Diluted Shares Outstanding,/,,shares,148311000.0
ImmunoGen Inc,IMGN,54930084U0R1OP766Y02,0000855654,2019.0,Q4,2019-10-01,2019-12-31,,,basicdilutedeps,Basic & Diluted Earnings per Share,=,,usdpershare,0.04
